| Nom |
Salinomycin |
| Nom anglais |
Salinomycin; (2r)-2-((5s)-6-{5-((10s,12r)-2-((6s,5r)-5-ethyl-5-hydroxy-6-methylperhydro-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)(1s,2s,3s,5r)-2-hydroxy-1,3-dimethyl-4-oxoheptyl}-5-methylperhydro-2h-pyran-2-yl)butanoic acid; (2R)-2-{(5S,6R)-6-[(2S,3S,4S,6R)-6-{(2S,5R,7S,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl}-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyltetrahydro-2H-pyran-2-yl}butanoic acid; sodium (2R)-2-{(2R,5S,6R)-6-[(1S,2S,3S,5R)-5-{(2S,5S,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl}-2-hydroxy-1,3-dimethyl-4-oxoheptyl]-5-methyltetrahydro-2H-pyran-2-yl}butanoate |
| Formule moléculaire |
C42H69NaO11 |
| Poids Moléculaire |
772.9804 |
| InChI |
InChI=1/C42H70O11.Na/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33;/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47);/q;+1/p-1/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41?,42-;/m0./s1 |
| Numéro de registre CAS |
53003-10-4 |
| EINECS |
258-290-1 |
| Structure moléculaire |
|
| Point de fusion |
112.5-113.5℃ |
| Point d'ébullition |
839.2°C at 760 mmHg |
| Point d'éclair |
243.2°C |
| Pression de vapeur |
1.04E-32mmHg at 25°C |
| Les symboles de danger |
 T:Toxic;
|
| Codes des risques |
R25:;
|
| Description de sécurité |
S45:;
|
|
FR
CN
CZ
DE
EN
ES
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
